Thermo Fisher Scientific Inc.
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
31.43%
Market Cap
169.35 Bil.
P/E Ratio
32.67
Dividend Yield
0.30 %
Earnings per Share
15.72 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 455.7 G | 0 Units |
| PRICE DETERMINATION TIME | 07/03/2026 / 11:17:39 AM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 456.7 | 455.2 |
| PREV. DAY'S PRICE | 455.7 | (07/02) |
| CHANGE DAY BEFORE | +0.00 | 0.00 % |
| 52 WEEK HIGH / LOW | 547.8 (01/22) | 339.15 (07/22) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 23.87 | 21.82 | 15.72 | 15.29 | 14.29 |
| DIVIDENDS PER SHARE | 1.76 | 1.64 | 1.52 | 1.44 | 1.29 |
| DIVIDEND YIELD IN % | - | - | 0.30 % | 0.30 % | 0.26 % |
| DIVIDEND GROWTH IN % | - | - | 5.72 % | 11.37 % | 13.48 % |
| PRICE - EARNINGS RATIO | 18.44 | 20.17 | 32.67 | 31.45 | 34.35 |
| PRICE - BOOK RATIO | - | - | 4.08 | 4.00 | 4.39 |
| PRICE - SALES RATIO | - | - | 4.92 | 4.65 | 4.81 |
| PRICE - CASH FLOW RATIO | - | - | 28.02 | 22.99 | 24.50 |
Master Data
| WKN | 857209 |
| ISIN | US8835561023 |
| SYMBOL | TN8 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Thermo Electron |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | 371.62 Mil. |
| MARKET CAPITALISATION | 169.35 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 3.88 % | 6.28 % | 5.28 % | -9.02 % | 31.43 % | -6.11 % | 4.99 % | -9.02 % |
| HIGH | 457.30 | 457.30 | 457.30 | 547.80 | 547.80 | 584.30 | 598.20 | 547.80 |
| LOW | 429.70 | 399.00 | 372.80 | 372.80 | 339.15 | 338.00 | 338.00 | 372.80 |
Dividend
per share
Company profile
Thermo Fisher Scientific Inc. offers products and services to customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of disease. The Analytical Instruments segment offers instruments and supporting consumables, software and services. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments and associated products to healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers outsourced services used by the pharmaceutical and biotech industries for drug development, clinical research, clinical trials services and commercial drug manufacturing. The company was founded in July 1956 and is headquartered in Waltham, MA.
Structured products for Thermo Fisher Scientific Inc.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.